Piet Jamaels

Piet Jamaels has over 25 years of work experience in various roles and industries. Piet is currently working as the Chief Operating Officer at Cerba Research since November 2022. Prior to this, they served as the Drug Development Lead and Head Project Management at Oxurion NV from January 2019 to November 2022.

Piet also has a significant tenure at GSK Vaccines, where they held several roles including Director of Performance, Process and Risk Management R&D from May 2016 to November 2018, Director of Performance Management R&D from April 2013 to April 2016, Director of Business Planning & Performance - Global Vaccine Development from November 2011 to April 2013, and Senior Manager of Operational Excellence from February 2010 to November 2011.

Before joining GSK Vaccines, Piet worked at GE Capital as the EMEA Client Operations Manager from March 2008 to February 2010. Prior to that, they held various positions at GE Corporate, including HR Services Leader from November 2006 to February 2008 and HR Transition Leader Benelux from June 2005 to October 2006.

Piet's early career includes roles at GE Healthcare as FP&A Manager from January 2004 to May 2005 and as a Strategic Marketing Analyst from March 2003 to December 2004. Piet also worked at KPMG Belgium as a Senior Audit Supervisor from September 1997 to February 2001.

Overall, Piet Jamaels has a diverse background with experience in leadership, project management, performance measurement, operational excellence, HR services, and financial analysis.

From 2002 to 2007, Piet Jamaels attended KU Leuven where they pursued a Masters degree in Commercial Engineering.